Allogene partners with Stanford for allogeneic CAR T production
Allogene will explore using mRNA technology for the development of allogeneic CAR-T therapies for the treatment of cancer.
Allogene will explore using mRNA technology for the development of allogeneic CAR-T therapies for the treatment of cancer.
CGT Catapult adds six additional clean room spaces to its Stevenage manufacturing center, to aid companies readying themselves for clinical and commercial manufacture.